Other Clinical Trial - Pathology Analysis of OPMD Patient Myotomies

Status Recruiting

Clinical Trial Summary

The study aims to characterize the effect of OPMD mutation on muscle function. Muscle samples will be received from oculopharyngeal muscular dystrophy (OPMD) patients who undergo cricopharyngeal muscle-cutting surgery, as part of their routine healthcare and treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Muscular Dystrophies
Muscular Dystrophy, Oculopharyngeal
Oculopharyngeal Muscular Dystrophy

Clinical Trial Details

NCT number	NCT03874910
Study type	Observational
Source	Hillel Yaffe Medical Center
Contact	Itzhak Braverman, Doctor (MD)
Phone	+972-4-6304549
Email	braverman@hy.health.gov.il
Status	Recruiting
Phase
Start date	March 19, 2019
Completion date	March 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02877784` - Screening in Oculopharyngeal Muscular Dystrophy
Recruiting	`NCT06185673` - A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia	Phase 1/Phase 2
Enrolling by invitation	`NCT04009408` - Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders	N/A
Withdrawn	`NCT04226924` - Treatment of Oculopharyngeal Muscular Dystrophy With Trehalose	Phase 2
Recruiting	`NCT02158156` - Effect of Aerobic Training in Patients With Oculopharyngeal Muscular Dystrophy	N/A
Completed	`NCT02015481` - Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients	Phase 2
Withdrawn	`NCT03161847` - Natural History Study of Oculopharyngeal Muscular Dystrophy